Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06872294

Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome AI-IVF Study

Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome in Women Affected by Autoimmune Disorders: From Biological Markers to Artificial Intelligence

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
Female
Age
18 Years – 43 Years
Healthy volunteers
Not accepted

Summary

Infertility is the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected intercourse, while subfertility means a delay in achieving pregnancy. Several factors can contribute to these conditions, such as autoimmune diseases like systemic thyroid and celiac diseases, rheumatoid arthritis, systemic lupus erythematosus, and endometriosis. Some of them may overlap, sharing a common immunological milieu. In this scenario, medically ART can help women carry on pregnancies if they are in stable disease remission and receive adequate treatment. However, the number of oocytes that can be ovulated under stimulation is highly variable, so the outcome of any IVF is linked to many factors, not only biological but also connected to the mean success rate of the fertility center. For these reasons, the need to find methods for identifying the best gametes and embryos to guarantee a successful pregnancy is becoming pressing. AI can be essential to develop prediction models for pregnancy outcomes for patients undergoing ART treatments. AI currently represents a modern way to obtain algorithms from a set of observable data that could help clinical decisions

Conditions

Timeline

Start date
2024-11-22
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-03-12
Last updated
2025-03-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06872294. Inclusion in this directory is not an endorsement.